Mydecine Innovations Group Archives

Psychedelics News

Mydecine Innovations Group

Industry

25 Apr 2023

Mydecine Reports Positive Preclinical Results on MYCO-006 Short-Acting MDMA Analogues

Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with...

By Microdose NewsDesk

Industry

19 Aug 2022

Hanging On or Closing Shop? Mydecine Announces $245K Financing

Today's announcement of a $245K in capital infusion could, perhaps, maybe, signal something hopeful for investors....

By Microdose NewsDesk

Industry

15 Aug 2022

Mydecine Board Members Resign

The departures are part of a larger organizational shift that will allow the corporation to concentrate on its core competencies with more efficiency....

By Microdose NewsDesk

Don’t Miss

25 Jul 2022

News You Might Have Missed: July 25th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

20 Jun 2022

FDA Clears Mydecine’s MYCO-001 for Government Funded Trial

The trial is funded by a near $4 million grant from the National Institutes of Health, making this the first time in 50 years the U....

By Microdose NewsDesk

Don’t Miss

20 Jun 2022

News You Might Have Missed: June 20th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Don’t Miss

13 Jun 2022

News You Might Have Missed: June 13th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Don’t Miss

30 May 2022

News You Might Have Missed: May 30th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Finance

27 May 2022

Mydecine Closes Capital Raise

Today Mydecine announced the closing of a larger capital raise — they issued 2,447,130 shares at a price of $1....

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result